How to use the speech recognition tool?

NCT04561466

BÉFINOHL

Study of the efficacy of Befizal® 200mg in the treatment of Leber’s hereditary optic neuropathy

Type: Interventional



Status of the trial: Active, Recruiting

Orphan Drug Recognition: Yes

Inclusion

  • Opening Date: 2019-03-01
  • Closing Date: 2022-03-01

Criteria

More information

Children: No

Adults: Yes

Funder Type: public

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Neuro-Ophthalmology Rare Diseases (WG2)

Subscribe to our mailing list

* indicates required

This ERN is supported by: